Valuation: Illumina, Inc.

Market Cap 28.82B 24.9B 23.39B 21.28B 40B 2,756B 40.66B 274B 107B 1,380B 108B 106B 4,587B P/E 2026 *
38.6x
P/E 2027 * 32.6x
Enterprise Value 29.07B 25.11B 23.59B 21.46B 40.34B 2,780B 41.01B 276B 108B 1,392B 109B 107B 4,626B EV / Sales 2026 *
6.29x
EV / Sales 2027 * 5.72x
Free-Float
74.97%
Yield 2026 *
-
Yield 2027 * -
1 day-0.91%
1 week+1.56%
Current month-6.93%
1 month+2.00%
3 months+33.92%
6 months+63.42%
Current year+45.54%
1 week 186.64
Extreme 186.64
194.5
1 month 178.88
Extreme 178.88
207
Current year 112.65
Extreme 112.65
207
1 year 88
Extreme 88
207
3 years 68.7
Extreme 68.7
207
5 years 68.7
Extreme 68.7
525
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 24/09/2023
Director of Finance/CFO 50 14/04/2024
Chief Tech/Sci/R&D Officer 55 28/05/2025
Director TitleAgeSince
Director/Board Member 65 27/07/2016
Director/Board Member 66 31/12/2016
Director/Board Member 65 04/02/2019
Date Insider Type Main position Quantity % Market Cap.
05/08/26
Corvex Management LP
SellCompany -283,269 0.1872%
05/08/26 Free

Executive/Senior Manager

15,011 0.0099%
04/08/26 Other

Director

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
-0.91%+1.56%+90.68%+8.45% 28.82B
-1.28%-0.96%+20.30%+10.08% 218B
-0.71%-1.13%-4.02%-20.68% 142B
-1.68%+4.14%-17.85%+28.66% 139B
+0.27%+5.11%-49.76%+0.29% 75.11B
-1.04%+2.10%+17.05%+14.70% 52.8B
+0.69%-0.51%-16.49%-15.50% 50.66B
-0.51%+1.75%+24.61%+18.21% 41.95B
-0.32%+1.31%+41.37%+44.38% 40.49B
-0.14%+2.68%+0.40%+4.47% 33.28B
Average -0.56%+1.76%+10.63%+9.31% 82.23B
Weighted average by Cap. -0.83%+1.24%+3.67%+7.55%

Financials

2026 *2027 *
Net sales 4.62B 3.99B 3.75B 3.41B 6.42B 442B 6.52B 43.98B 17.2B 221B 17.36B 16.99B 736B 4.91B 4.24B 3.99B 3.62B 6.81B 470B 6.93B 46.7B 18.26B 235B 18.44B 18.04B 781B
Net income 760M 657M 617M 561M 1.06B 72.71B 1.07B 7.23B 2.83B 36.41B 2.85B 2.79B 121B 891M 770M 723M 658M 1.24B 85.22B 1.26B 8.48B 3.31B 42.68B 3.35B 3.27B 142B
Net Debt 246M 212M 200M 182M 341M 23.53B 347M 2.34B 915M 11.78B 924M 904M 39.15B -729M -630M -592M -538M -1.01B -69.71B -1.03B -6.93B -2.71B -34.91B -2.74B -2.68B -116B
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
14/08/26 US$190.89 -0.91% 993,080
13/08/26 US$192.64 -0.14% 1,061,432
12/08/26 US$192.91 +0.04% 1,256,641
11/08/26 US$192.84 +0.55% 867,974
10/08/26 US$191.79 +2.04% 1,687,721
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
190.89USD
Average target price
198.89USD
Spread / Average Target
+4.19%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock